% | $
Quotes you view appear here for quick access.

Alexion Pharmaceuticals, Inc. Message Board

  • lunaris1 lunaris1 Sep 19, 2013 8:33 AM Flag

    BioMarin Surges on Report Roche Seeking Takeover Financing : Dealreporter says

    BioMarin Pharmaceutical Inc. gained after DealReporter said Roche Holding AG is lining up $15 billion in debt financing for an acquisition of the maker of drugs to treat rare diseases.
    Roche may have to pay $95 to $105 a share for the Novato, California-based company, DealReporter said, citing people familiar with the situation. The lower end of the range would be a 23 percent premium to BioMarin’s closing level yesterday of $77.49, and would value the company at about $13.5 billion.

    For me it's wrong... for you guys ?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
146.67+4.16(+2.92%)May 24 4:00 PMEDT